A recent study indicates that patients who discontinue new slimming jabs like semaglutide or tirzepatide tend to recover reduced body mass much more quickly than those who halt conventional diet and exercise programs.
Published data in a leading health publication points out that while overweight individuals often shed a large proportion of their body weight while undergoing treatment, the mass is regained at an average rate of nearly a kilo each month upon discontinuation.
"Users purchasing these drugs must be aware of the potential of rapid rebound weight gain when the therapy concludes," cautioned researcher Dr. Susan Jebb.
Such speed of regain suggests a return to starting weight within about one and a half years.
Comparing Treatments
The study, which looked at dozens of studies involving over 9,000 of patients, contrasted the outcomes of these new drugs with older methods.
Researchers point out that individuals who lose weight through lifestyle changes alone generally see a more gradual weight regain—around 0.1 kg a month—post-intervention.
The Reason for the Rapid Regain
Experts believe the way of the injections explains the accelerated regain.
GLP-1 drugs imitate a body's own chemical called glucagon-like peptide-1, which helps regulate appetite.
"Sustained high doses of GLP-1 levels far above than normal could lead to the system to generate a reduced amount of its own natural GLP-1, and could reduce responsiveness to its effects," noted Dr. Adam Collins, a dietetics researcher.
"Withdrawal of this medication means appetite is no longer kept in check, making binge eating far more likely."
A Lifelong Condition?
The NHS suggest the injections for people with weight-linked medical conditions, alongside prescribed diet and exercise modifications.
A number of clinicians argue that, due to the significant potential of weight regain, the treatment is often life-long.
This opinion is reinforced by pharmaceutical companies, who note that the findings "underscore the chronic character of excess weight," comparing it to managing diseases like hypertension.
Patient Testimonies
People who have stopped the medication describe a intense return of appetite.
"It was like something that goes on and you're instantly extremely hungry," recalled an individual.
This challenge is exacerbated if individuals have not established lasting lifestyle or habit changes during treatment.
Widespread Use
Recent estimates suggest that a significant number of people in the UK have tried these injections in the past year, with demand being substantial.
- Use is higher among females compared to males.
- The 40s and 50s demographic shows the greatest level of interest.
- A large proportion obtain the drugs through private healthcare rather than the NHS.
Ultimately, researchers emphasize that while GLP-1 drugs are potent tools for weight loss, they are not a standalone solution and maintained weight loss likely depends on combined behavioural changes.